1. Reed SG, Pihl DL, Conlon PJ, Grabstein KH. IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. J Immunol 1989; 142: 3129–3133.
2. Killar LM, Hatfield Carding SR, Pan, M Winterrowd, GE Bottomly, K.In vivo administration of interleukin-1 elicits increased Ia antigen expression on B cells through the induction of interleukin-4. Eur J Immunol 1989; 19: 2205–2210.
3. Yamashita U, Shirakawa F. Restoration of impaired T cell functions in tumor-bearing mice by the administration of interleukin-1. Jap J Cancer Res (Gann) 1987; 78: 270–278.
4. Frasca DD, Boraschi S, Baschieri P, Possu A, Tagliabue A, Adorini L, Doria G.In vivo restoration of T cell functions by human IL-1B or its 163–171 nonapeptide in immunodepressed mice. J Immunol 1988; 140: 2651–2655.
5. North RJ, Neubauer RH, Huang JJH, Newton RC, Loveless SE. Interleukin-1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host comitant immunity. J Exp Med 1988; 168: 2031–2043.